Skip to content

SPRINT QUATTRO SECURE® DXAC/DSP 6947100Recalls & reported problems

Medtronic, Inc. · LEAD 6947100 SPRINT QUATTRO US SI MCRD · Class 3 · Implant

All models of Medtronic Sprint Quattro Lead (67) · SPRINT QUATTRO SECURE DXAC/DSP (7)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169535978), received between Feb 9, 2017 and Feb 9, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 9, 2017Break; Break

    IT WAS REPORTED THAT THE LEAD WAS ATTEMPTED TO BE IMPLANTED BUT NOT USED. THE PHYSICIAN NOTICED THAT THE DISTAL PART OF THE SUPERIOR VENA CAVA (SVC) COIL WAS DAMAGED/STRETCHED. THE LEAD WAS REMOVED FROM SERVICE AND A NEW LEAD WAS IMPLANTED. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 6317908 ↗

Other Permanent defibrillator electrodes devices

All Permanent defibrillator electrodes devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page